MarketPeel
Insider Trading Intelligence
PL

Perceptive Ls (a), Llc

LYRA
10% OWNER · LYRA THERAPEUTICS, INC. · CIK 0001797811
FILING MIX · LIFETIME32%/68%
BUYS
9
SELLS
19
TOTAL VALUE
$52.83M
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
14,026
AVG SELL PX
$12.45
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 24 pending
Forward-return performance of every backtestable P/S trade by Perceptive Ls (a), Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+87.50%-11.20%-1.03%-10.16%-12.88%
14d16+87.50%-18.18%-0.47%-17.71%-21.83%
30d16+87.50%-0.78%+1.60%-2.38%-8.04%
60d16+87.50%-22.23%+2.95%-25.17%-30.22%
90d16+87.50%-44.52%+2.58%-47.10%-63.65%
180d16+87.50%-61.84%+7.63%-69.47%-90.88%
1y16(12 pending)+0.00%-70.74%+24.01%-94.75%-105.44%
2y16(12 pending)+0.00%-66.98%+40.16%-107.14%-126.71%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LYRA · 14,026 shares · as of Nov 13, 2025
02,867,2795,734,5598,601,83811,469,11720212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 9 buys / 19 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LYRA
LYRA THERAPEUTICS, INC.
SALE
28,597$3.90$111.5K124,859Nov 13, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
3,213$3.90$12.5K14,026Nov 13, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
7,862$4.06$31.9K153,456Nov 12, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
883$4.06$3.6K17,239Nov 12, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
537$4.31$2.3K18,122Nov 11, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
4,783$4.31$20.6K161,318Nov 11, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
1,869$4.54$8.5K18,659Nov 10, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
16,633$4.54$75.5K166,101Nov 10, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
17,746$4.75$84.2K182,734Nov 7, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
1,993$4.75$9.5K20,528Nov 7, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
28,902$5.18$149.7K200,480Nov 6, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
3,247$5.18$16.8K22,521Nov 6, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
3,610,832$2.49$9.00M11,469,117May 31, 2023Jun 2, 2023View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
1,805,4161,805,416May 31, 2023Jun 2, 2023View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
5,924,170$4.22$25.00M7,858,285Apr 12, 2022Apr 14, 2022View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
183,174$16.00$2.93M1,288,446May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
1,132,0161,132,016May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
141,221$8.63$1.22M1,385,287May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
470,7391,244,066May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
16,232,5110May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
339,604$8.63$2.93M1,471,620May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
39,035,3250May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
773,327773,327May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
76,172$16.00$1.22M1,309,115May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
339,6040May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
141,2210May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
26,666,6660May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
625,000$16.00$10.00M1,934,115May 5, 2020May 29, 2020View →
Other insiders · LYRA
Loading peer insiders…
About this filer
CIK 0001797811
ROLE
10% Owner
PRIMARY
LYRA
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001797811DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback